Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Hautarzt ; 71(11): 870-879, 2020 Nov.
Artigo em Alemão | MEDLINE | ID: mdl-32997218

RESUMO

Vasculitis is a rare cause of skin ulceration. Depending on the size of the affected vessel, the patient's comorbidities and the pathophysiology present, different clinical morphologies can be seen, which can often give preliminary indications of the type of underlying vasculitis. There may be systemic or cutaneous manifestations; thus, a targeted diagnostic workup should be initiated at an early stage. Treatment should be interdisciplinary if there is systemic participation. Vasculopathies (e.g., livedoid vasculopathy), in which occlusion of the vascular lumen is the main pathophysiological feature, should be delimitated from vasculitis. If vasculitic or vasculopathic ulceration is present, stage-appropriate wound management is recommended.


Assuntos
Dermatopatias Vasculares , Úlcera Cutânea , Vasculite , Diagnóstico Diferencial , Humanos , Dermatopatias Vasculares/diagnóstico , Dermatopatias Vasculares/terapia , Úlcera Cutânea/diagnóstico , Úlcera Cutânea/terapia , Vasculite/diagnóstico , Vasculite/terapia
2.
Hautarzt ; 64(9): 685-94, 2013 Sep.
Artigo em Alemão | MEDLINE | ID: mdl-24022632

RESUMO

BACKGROUND: Phlebologic diseases have become extremely common and have major socio-economic impact. However, the percentage of dermatologists working in phlebology appears to be decreasing according to the data of the German Society of Phlebology (DGP). METHODS: To investigate the reasons for this development, we--on behalf of the DGP--sent a questionnaire to 120 German Departments of Dermatology in autumn 2012. RESULTS: In 76 returned questionnaires, the number of physicians with additional fellowship training in phlebology averaged 1.5; the average number of those who fulfill the criteria for training fellows in phlebology was 0.9. In 71.1 % of the departments there was a phlebologist. A special phlebologic outpatient clinic existed in 73.7 % of the departments. Sonography with Doppler (89.5 %) and duplex (86.8 %) was used as the most frequent diagnostic tool. For therapy, compression (94.7 %), sclerotherapy (liquid 78.9 %, foam 63.2 %, catheter 18.4 %), endoluminal thermic procedures (radio wave 28.9 %, laser 17.1 %) and surgery (especially crossectomy and stripping 67.1 %, phlebectomy of tributaries 75 %) were used. The average number of treatments was very heterogenous in the different departments. CONCLUSIONS: Phlebology definitely plays an important role in dermatology. Most departments fulfill the formal criteria for the license to conduct advanced training in phlebology. A wide spectrum of phlebological diagnostic and therapeutic procedures is available.


Assuntos
Dermatologia/estatística & dados numéricos , Departamentos Hospitalares/estatística & dados numéricos , Padrões de Prática Médica/estatística & dados numéricos , Dermatopatias Vasculares/diagnóstico , Dermatopatias Vasculares/terapia , Insuficiência Venosa/diagnóstico , Insuficiência Venosa/terapia , Alemanha/epidemiologia , Humanos , Competência Profissional/estatística & dados numéricos , Dermatopatias Vasculares/epidemiologia , Inquéritos e Questionários , Insuficiência Venosa/epidemiologia
3.
Hautarzt ; 61(8): 705-16; quiz 717-8, 2010 Aug.
Artigo em Alemão | MEDLINE | ID: mdl-20644902

RESUMO

The coagulation system protects the body from uncontrolled blood loss by means of highly regulated processes. In case of an injury the coagulation system instantly switches from controlled blood flow to acute coagulation and thrombus formation with the goal of stopping the blood loss. Minor changes in this well-maintained equilibrium of coagulation and blood flow tip the balance towards uncontrolled blood loss or even fatal thromboembolic events. Iatrogenic manipulation of this highly regulated system is possible with a variety of therapeutic agents. We review the basics of coagulation physiology and then discuss dermatologically relevant aspects of thrombosis prevention, as well as the use of anticoagulants to treat dermatologic diseases.


Assuntos
Anticoagulantes/uso terapêutico , Dermatopatias/tratamento farmacológico , Tromboflebite/tratamento farmacológico , Coagulação Intravascular Disseminada/sangue , Coagulação Intravascular Disseminada/tratamento farmacológico , Erisipela/sangue , Erisipela/tratamento farmacológico , Hemangioma/tratamento farmacológico , Hemangioma Capilar/sangue , Hemangioma Capilar/tratamento farmacológico , Hemostasia/efeitos dos fármacos , Hemostasia/fisiologia , Humanos , Síndrome de Kasabach-Merritt , Dermatopatias/sangue , Neoplasias Cutâneas/tratamento farmacológico , Síndrome de Sneddon/sangue , Síndrome de Sneddon/tratamento farmacológico , Síndrome de Stevens-Johnson/sangue , Síndrome de Stevens-Johnson/tratamento farmacológico , Tromboflebite/sangue , Trombose Venosa/sangue , Trombose Venosa/prevenção & controle
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA